INTRODUCTION
Particular attention has recently been directed toward the role of cell-mediated immunity in the synovial inflammation characteristic of rheumatoid arthritis (RAV) . This interest has been prompted by the observations of several investigators that suggest that the chronic joint inflammation of RA may result from local immune responses to antigens present in the synovial tissues (1, 2) . Support for this concept includes the identification of perivascular accumulations of macrophages in close association with lymphocytes in various stages of transformation in rheumatoid synovial tissues (3) and the presence of immunoglobulin-producing plasma cells (4, 5) , thymus-dependent lymphocytes (T cells) (6, 7) , and lymphokines (8) in both the synovial membrane and the synovial fluid of rheumatoid patients. The most impressive correlation between cell-mediated immunity and rheumatoid joint inflammation has been the striking clinical improvement of patients with severe rheumatoid disease after depletion of circulating T cells by prolonged thoracic duct drainage (2, 9) . The therapeutic benefits of immunosuppressive drugs, such as cyclophosphamide and azathioprine in the treatment of RA (10) , also implicate 'Abbreviations used in this paper: FBS, fetal bovine serum; MEM, minimum essential medium, M-H, Mantel lymphocytes as significant elements in the pathogenesis of RA.
In vitro studies have suggested that lymphocytes from patients with RA express cell-mediated immunity to antigens present in rheumatoid but not in normal synovial tissues and fluid (11) (12) (13) . Based on these preliminary reports, this investigation was undertaken to determine if a specific immune reactivity of rheumatoid lymphocytes toward rheumatoid synovial cells grown in tissue culture could be demonstrated in vitro. The cytotoxic activity of rheumatoid and normal peripheral blood lymphocytes against monolayer cultures of fibroblasts derived from rheumatoid and nonrheumatoid synovium has been compared with chromium-51 release assays.
METHODS
Source of synovial tissues. Synovial tissue specimens were obtained from patients at the time of therapeutic surgical synovectomy or reconstructive joint surgery (Table  I) . Nonrheumatoid synovia were predominantly specimens obtained from the hip joints of patients with a clinical diagnosis of osteoarthritis. RA synovia specimens originated primarily from the knee, hand, and wrist joints of patients with definite or classical RA, based on the criteria of the American Rheumatism Association. The ages of the donors of rheumatoid and nonrheumatoid synovia were similar, while the proportion of women was higher in the rheumatoid group.
At the time of explanation, typical samples of dissected synovial tissue were fixed in formalin and examined histologically to confirm the presence of synovial membrane and the presence or absence of the inflammation, synovial cell hyperplasia, and lymphocytic infiltration characteristic of rheumatoid synovitis.
SynorAal cell cultures. Monolayer cell cultures derived from the synovia of 38 patients (15 RA, 23 non-RA) were used in this study (Table I) . Explant cultures of synovial lining tissue were established as previously described (14, 15) . Initially, six explants of synovial tissue (approximately 1-2 mm in diameter) were seeded in each of several 25 cm' tissue culture flasks (Falcon, BioQuest, Oxnard, Calif.). Fibroblastic cells migrating from these explants were termed "pass 1" cells. When the monolayers reached confluency (4-6 wk), the cells from two 25-cm' flasks were passaged to one 75-cm' plastic flask (1: 1.5 split) and termed "pass 2" cells. Subsequent subculturing of individual cell lines was performed as the monolayers reached confluency (0.25% trypsin in phosphate-buffered saline) and were at split ratios of 1: 2. All cell lines were maintained at 37'C, in a room air environment with Lebovitz medium (Flow Laboratories, Inc., Rockville, Md.) supplemented with 10% heat-inactivated fetal bovine serum (Flow Laboratories), glutamine (0.3 mg/ml), penicillin (100 U/ml), and gentamicin (40 ,g/ml).
By continual subculturing, synovial cell lines could be maintained in culture for up to 2 yr (mean life-span, 10 mo), and thus provided a constant supply of synovial cells for study. The morphologic appearance and the growth characteristics of our synovial cell cultures were similar to those described by Bartfeld (16) and Castor and Fries (17) . Samples of synovial tissue specimens were monitored for bacterial contamination by inoculation into trypticase soy broth and for mycoplasmal contamination as previously described (18) . These tests were repeated on all cell lines in which a high cell-mediated cytotoxicity response was obtained in the "Cr-release assay and were routinely performed at 6-mo intervals on all synovial cell lines.
Source and preparation of lymphocytes. Lymphocytes from 40 Caucasian patients with RA (12 men and 28 women) were tested for cytotoxic activity against synovial cells in vitro. All patients were being followed in the Arthritis Clinic, University of Utah Medical Center, and the diagnosis of definite or classical RA was established according to American Rheumatism Association approved criteria. Tests for serum rheumatoid factor by latex fixation were negative in 15% of the patients. Drug therapy at the time of assay was restricted to aspirin and/or gold. The age of the patients varied from 21 to 80 yr (mean age 51) and the mean duration of disease was 11 yr (range 1-27 yr). 22% of the patients had undergone orthopedic surgery in the past, but none had been transfused. 25 healthy Caucasian laboratory personnel (9 women and 16 men) with ages ranging from 18 to 55 yr (mean age 32 yr) served as a source of normal lymphocytes for control studies.
Lymphocytes were prepared from heparinized (10 U/ml, preservative-free) peripheral blood samples by the FicollHypaque technique of Boyum (19) and washed three times in Hanks' balanced salt solution containing 5% heat-inactivated fetal bovine serum (FBS). Cell for 1 h at 37'C. All lots of "Cr were discarded after one half-life.
After 5"Cr exposure, the cells were centrifuged at 200 g for 10 min and the supernates were carefully removed with suction and discarded. The labeled cells were then washed three times by resuspension in 10-ml volumes of MEM-FBS and centrifugation (200 g, 10 min). During the washing procedure, the MEM-FBS was kept at 37°C and all centrifugations were at room temperature. During preliminary studies, this procedure was shown to result in target cell suspensions in which 90-95% of the radioactivity was sedimentable at 200 g in 10 min and in which target cell viability was 90-94% by trypan blue dye exclusion. The washed, labeled cells were then resuspended in Dulbecco's medium supplemented with 15 mM Hepes buffer (pH 7.3, Flow Laboratories), glutamine (0.3 mg/ml), penicillin (100 U/ ml), streptomycin (100 gg/ml), and 10%o FBS (Dulbecco-FBS). Labeled cells, 10' in 0.2 ml medium, were added to the wells of Falcon Microtest II tissue cultures plates. The plates were covered with plastic film (Falcon, 3044) and incubated overnight at 370 C in a room air atmosphere.
During this time, the cells attached to the bottom of the well as a confluent monolayer.
After 24 h, the medium was removed by rapidly inverting the plate and then blotting the plate surface on sterile gauze. Dehydration of the monolayers was prevented by quickly adding fresh medium (0.1 ml) to all but six wells. Lymphocytes (106 cells in 0.1 ml media) were then added to the test wells and additional medium (0.1 ml) was added to the media control wells. The final volume of media and test wells was 0.2 ml. Trypsin (0.2 ml, 0.25%o in PBS) was then added to the six reserved wells for later determination of the total radioactivity present in the monolayers. The plates were again covered with film and incubated for 18 h in a room air environment at 37°C.
The plates were then placed on a slight incline and the supernates were removed from one side of the well with a Pasteur pipet drawn to a fine point. Care was taken not to disturb the attached monolayers in the media and test wells. Each supernate was transferred to an individual counting vial and the amount of released 'Cr was measured in a crystal scintillation spectrophotometer (Biogamma, Beckman Instruments, Inc., Fullerton, Calif.). The trypsin wells were similarly harvested and, in addition, were rinsed three times with 0.2 ml distilled water. The rinses from each trypsin well were combined with the corresponding trypsin supernate for determination of the total radioactivity present per well. Microscopic observation of the trypsin wells confirmed lysis and removal of the target monolayer by this procedure. Assays were performed in replicates of six wells and 1 SD from the mean counts per minute was routinely less than ± 10% of the mean. The mean endogenous release of 'Cr from target cells cultured in the absence of lymphocytes (mean cpm of six media wells) during the 18-h incubation ranged from 15 to 22%o of the mean total cpm per well. Total radioactivity per well, as determined from the mean of the six trypsin wells, ranged from 3,000 to 6,000 cpm. Synovial cells labeled with 'Cr formed stable monolayers under these assay conditions. The mean recovery of radioactivity (cpm) in the target monolayers (trypsin wells) after the initial 24-h preincubation was 85.6%'o of the cpm expected in the monolayer if 100%o of the labeled cells had survived (mean of 15 determinations on different RA and non-RA synovial cell lines; range 60-95%o). The expected cpm was calculated from the total cpm originally added to the wells as cell-bound 'Cr, and an endogenous release of 5tCr into the media of 1%/h during this 24-h preincubation. Recovery of radioactivity in the target monolayer correlated well with the results of preliminary studies in which the relative recovery of unlabeled target cells was determined.
In these studies confluent monolayers were trypsinized, ' Two forms of scoring x and y's, defined below, were used in the M-H procedure. One form was used to test the association between number of passages and cell lysis, controlled for lymphocyte donor type and target cell type (Table II) . For each control factor combination (e.g., RAL and RAF), a one degree of freedom chi square was given by: M-H x'=[S-E(S)]2/V(S); where S=2xy with Summary chi squares, also with one degree of freedom, and P values were obtained by summing for the control factor categories to be combined thus: summary M-H x'= [ZS -ME(S)]2/ZV(S). (Table   III) and donor type (Table IV) , the x scores were the same as above; however, for (a) target cell type y = 1, if RAF, and y =0, if NF; and for (b) lymphocyte type y = 1, if RAL, and y = 0, if NL. In these last two analyses, (a) and (b), target cell passage was controlled with three ranges (2-5, 6-9, and 10 or more). The lines presented in Fig. 3 were fitted by the method of least squares (22) to indicate trends. The scatter of points was so great, even after controlling for donor and target cell types, that these lines should not be construed to mean that we believe the relationship between percent lysis and target cell pass number to be linear.
RESULTS
Characteristics of synovial cells as targets for "Cr release assays. Studies were carried out to determine the suitability of RA and non-RA synovial cells as targets for lymphocyte-mediated cytotoxicity assays. Since these cell lines ar,e maintained as monolayer cultures and, therefore, undergo trypsinization before labeling with 'Cr, a standard 24-h incubation of 'Cr-labeled target cells was instituted to allow cell attachment to the surface of the wells and regeneration of any membrane antigens that might have been removed by the trypsinization procedure.
Rheumatoid and nonrheumatoid synovial cells were susceptible to lysis under assay conditions in which mitog,en-stimulated lymphocytes were used as aggressor cells. In studies with normal lymphocytes pretreated with PHA, 85-90% of the bound 'Cr was released from the target cells during 24 h. PHA was also used to activate normal lymphocytes during 24 h of co-cultivation with 'Cr-labeled target cells. Under these conditions, the mean percent lysis at 24 h calculated from 23 determinations with 18 different synovial cell lines (10 non-RA and 8 RA) was 17% (range 7.7-30.2%) in the presence of PHA as compared to 4.6% (range 1.9-9.4%) in the absence of PHA.
Comparison of the cytotoxic activity of rheumatoid and normal lymphocytes against allogeneic rheumatoid and nonrheumatoid synovial cells. The cytotoxic activity of RAL and NL against allogeneic cell lines derived from both rheumatoid and nonrheumatoid synovium (synovial cells) were compared. In a typical assay, lymphocytes from one to three normal donors and one to four RA patients were simultaneously tested for cytotoxic activity against several RA and non-RA synovial cell lines. In the latter part of the study, both younger and older cell lines were included in each assay. The results of 400 assays are presented in Fig.  1 . Although there was a tendency for high lysis values (> 10%) to cluster in the rheumatoid lymphocyte groups, both the mean values of percent lysis (6.0- results, it was noted that the higher values for percent lysis (> 10%) seen with RAL were observed primarily when synovial cells from very young cultures were used as target cells; i.e., lines subcultured only two to six times (Fig. 2) . The data were subjected to statistical analysis to determine the significance of the effect of target cell age on the results of the cytotoxicity assays (Table II) . Age of target cells did not significantly affect the results of cytotoxicity assays in which normal lymphocytes were tested (P = 0.94). In contrast, rheumatoid lymphocytes demonstrated much greater cytotoxic activity against synovial cells from young cultures as compared to older cultures (P < 0.001), and this association was significant for both rheumatoid (P = 0.029) and nonrheumatoid (P = 0.0035) synovial cells.
Since the number of times that the synovial cells had been subcultured appreciably influenced the frequency and extent of target cell lysis affected by rheumatoid lymphocytes, the assay results were grouped according to target cell age, as shown in Table III . Two analyses were then made that controlled for the age of the target cells. In the first analysis (Table IV) , the cytotoxic activity of RA lymphocytes for synovial cells was compared with that of non-RA lymphocytes. In the second analysis (Table V) , the susceptibility to lysis of RA vs. non-RA synovial cells was compared.
Significance values from a comparison of the relative cytotoxic activity of rheumatoid versus normal lymphocytes when tested against young, medium, and older synovial cell cultures are presented in Table IV . In the summary analysis, the overall cytotoxic activity of rheumatoid lymphocytes against synovial cells was significantly greater than that of normal lymphocytes (P = 0.015). When the significance values calculated for the three target cell age groups were compared, however, this apparently greater cytotoxic activity of rheumatoid lymphocytes was found to be highly significant only when young target cells (pass 2-5) were considered (P = 0.0042) and was not significant when target cells from older cultures were tested (P = 0.62; P > 0.9).
Since differences in the cytotoxic activity of rheumatoid and normal lymphocytes were most prominent when young synovial target cells were used, it was expected that any disease-specific immune response The data presented in Table V , however, show that differences in susceptibility to lysis between RA and non-RA synovial cells do arise after maintenance in tissue culture for several generations. Both rheumatoid and normal lymphocytes showed significantly greater cytotoxic activity against older RA cell cultures than against older non-RA cell cultures (P = 0.0048). This finding suggests a difference between RA and non-RA synovial cells in vitro, evidenced primarily in older cell cultures and detected by both rheumatoid and normal lymphocytes.
Although in the group analysis presented in Table  IV , RA lymphocytes were shown to have a greater cytotoxic activity against synovial cells than normal lymphocytes, it was readily evident that lymphocytes from the majority of patients with RA were nonreactive in the cytotoxicity assays. To identify those patients whose lymphocytes were repeatedly cytotoxic against synovial cells, lymphocyte donors were arbitrarily scored as high or low reactors in this assay system on the basis of demonstration of 11% or more lysis toward a minimum of two different synovial cell lines. By these criteria, 8 of the RA donors (20%), but only 1 of the 25 normal donors (4%), were considered high reactors. The effect of age in culture on the percent lysis values obtained when lymphocytes from the reactive rheumatoid group (R-RAL) and the nonreactive group (NR-RAL) were tested against RA and non-RA synovial cells is presented in Fig. 3 . These data substantiate and graphically demonstrate the conclusions drawn from the statistical analyses of the entire RA patient group. Lymphocytes from these eight patients were found to be reactive to young cultures of both RA and non-RA synovial cells. When results of simultaneous assays with lymphocytes from these same patients and older synovial target cells were compared, greater lysis of RA target cells than of non-RA target cells was observed.
We were unable to differentiate these eight patients from the RA patient group as a whole on the basis of age (mean 48 yr; range 21-64 yr), sex (three men, five women), duration of symptoms (mean 8 yr; range 1-16 yr), number of pregnancies among the female patients (none to three), drug regimen (aspirin, three patients; gold, five patients). Three of these eight patients had undergone major surgery in the past, and none had received blood transfusions. Two patients were sero-negative, and six were sero-positive for rheumatoid factor by latex fixation tests. Test of rheumatoid lymphocytes for cytotoxic activity against autologous synovial ceUs. The cytotoxic activity of rheumatoid and nonrheumatoid lymphocytes against autologous synovial cells was investigated in 11 patients (Fig. 4) . In each case, the autologous synovial target cells under consideration were at pass 2-6. lines, although lymphocytes from two of these same donors did show increased cytotoxic activity against young allogeneic synovial cells. In control studies in which lymphocytes from two patients with osteoarthritis were tested against autologous and allogeneic synovial cell lines, no significant lysis of target cells was observed (Fig. 4) . DISCUSSION As pointed out in the introduction, rheumatoid synovitis may be due to local humoral and cell-mediated immune responses to antigens present in the inflamed synovial tissues (1, 2). Our study was initiated in an attempt to identify, in fibroblast cultures derived from the syrnovia of rheumatoid patients, an antigen (either foreign or self) that might have an etiologic or disease-perpetuating relationship to RA. Although we could not demonstrate a specific immune response of rheumatoid lymphocytes toward rheumatoid synovial cells, the results are of interest in that they demonstrate differences both between rheumatoid and normal lymphocytes and between rheumatoid and nonrheumatoid synovial cells.
Previous attempts to demonstrate immunity in RA patients to antigens unique to rheumatoid synovial tissue by in vitro techniques have been for the most part inconclusive. For example, other investigators have utilized fresh synovial tissue and synovial fluid as an antigen source in demonstrating disease-related immune reactivity in RA patients by lymphocyte blast transformation or leukocyte migration inhibition assays (11) (12) (13) . However, the possibility that the immune responses ob-serv-ed in vitro were due to imimiuine complexes or preexisting lymphokines arising fronm in vivo immune activity in the synovium wvas not excluded.
The cytotoxic activity of rheumiiatoid lymiphocytes xvhen tested agaiinst humiian cell lines hals been insvestigated by a inulmiber-of groups wvith coniflictinlg results.
Initial reports that peripheral blood lymphocytes fromi rheumiiatoid patients were cvtotoxic for hulmiain svnovial cells (23) and hunman embryonic fibroblasts (24) were uncoinfirmiied by later investigations (25) (26) (27) (28) . In these initial studies, long-terml incubations (48-72 h) of lNyphocytes witlh allogeneic target cells were employ ed, and the possibility that the observed target cell lysis resulted from in Vitro sensitization of lymphocytes toward target cell alloantigeins (29) was not excluded. In contrast, Hedsberg (27) (32) .
Althouglh the series is simialler, our autologous studies do not totally supp)ort the conclusion drawn from the allogeneic studies anid are, in fact, similar to those of Glhose et al. (31 ) In summary, our study demonstrates that lymphocytes from some rheumatoid patients show greater cytotoxic activity against young allogeneic synovial cells than do normal lymphocytes, as measured by MCr release from the target cells in 18 h. However, we found no evidence for specific lysis of RA synovial cells by RA peripheral lymphocytes. The age in culture of the synovial target cells was shown to influence greatly the extent of observed lysis and thus should be considered in analysis of data arising from studies of this type. Data from the allogeneic studies could be interpreted on the basis of immunity to normal synovial cell antigens. However, the autologous studies did not support this conclusion and indicated that the results may have represented in vitro activation of generally more aggressive RA lymphocytes. Further autologous studies, in conjunction with an investigation of the effects of age in culture on the susceptibility of synovial cells to cell-mediated lysis, will be necessary to differentiate between these two possibilities.
